Outlook Therapeutics' Annual Loss Per Share Narrows in FY24; Shares Up

MT Newswires Live
2024-12-27

Shares of Outlook Therapeutics (OTLK) were up Friday after the biopharmaceutical company reported a loss of $4.06 per share for fiscal 2024, narrowing from a loss of $4.72 a year earlier.

Six analysts surveyed by FactSet estimated a loss of $4.91 per share.

The company didn't report any revenue for the year ended Sept. 30.

Price: 1.96, Change: +0.26, Percent Change: +15.35

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10